Search Results - "Sidgiddi, Srinivas"

Non-alcoholic fatty liver disease: need for a balanced nutritional source by Veena, Jayagopalan, Muragundla, Anjaneyulu, Sidgiddi, Srinivas, Subramaniam, Swaminathan

“…Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are an increasingly common chronic liver disease closely associated with…”
Get full text

Effect of a New Head Lice Treatment, Abametapir Lotion, 0.74%, on Louse Eggs: A Randomized, Double-Blind Study by Bowles, Vernon Morrison, Hanegraaf, Sharon, Ahveninen, Tiina, Sidgiddi, Srinivas, Allenby, Kent, Alsop, Hugh

“…Few head lice treatments have demonstrated effectiveness against louse eggs. Abametapir, a metalloproteinase inhibitor, is able to target metalloproteinases…”
Get full text

53889 Impact of DFD-29, a Low-Dose Oral Minocycline, on Skin, Gastrointestinal Tract, and Vaginal Microflora in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial by Sidgiddi, Srinivas, Bhatia, Neal

Get full text

Comparative Bioavailability of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) Vs. Minocycline Hydrochloride Extended Release 105-mg tablets After a Single Oral Dose: A Randomized, 3-way Crossover Study by Sidgiddi, Srinivas, Gautam, Aniruddh

“…Background: A low-dose formulation (DFD-29) of minocycline hydrochloride (HCl) is under evaluation for the treatment of moderate-to-severe papulopustular…”
Get full text

Dermal and Systemic Pharmacokinetics of Oral DFD-29 (minocycline hydrochloride modified release capsules, 40 mg) vs Oral Doxycycline 40 mg in Healthy Subjects by Hebert, Adelaide A., Sidgiddi, Srinivas

“…Dermal and Systemic Pharmacokinetics of Oral DFD-29 (minocycline hydrochloride modified release capsules, 40 mg) vs Oral Doxycycline 40 mg in Healthy Subjects…”
Get full text

Efficacy, Safety, and Potency of Betamethasone Dipropionate Spray 0.05: A Treatment for Adults with Mild-to-moderate Plaque Psoriasis by Sidgiddi, Srinivas, Pakunlu, Refika I., Allenby, Kent

“…Objective: A spray formulation of betamethasone dipropionate 0.05% (BD spray 0.05%; Sernivo™ [betamethasone dipropionate] Spray 0.05%; Promius Pharma, LLC;…”
Get full text

Bioavailability, Pharmacokinetics, and Transepidermal Water Loss of Short Contact Tazarotene Lotion 0.1% Versus Tazarotene (Tazorac®) Cream 0.1 by Sidgiddi, Srinivas, Allenby, Kent, Okumu, Franklin, Gautam, Anirudh

“…Objective: Two clinical studies were conducted to 1) assess the pharmacokinetic (PK) properties of tazarotene and tazarotenic acid in DFD-03 lotion (a…”
Get full text

Efficacy, Safety, and Potency of Betamethasone Dipropionate Spray 0.05%: A Treatment for Adults with Mild-to-moderate Plaque Psoriasis by Sidgiddi, Srinivas, Pakunlu, Refika I, Allenby, Kent

“…A spray formulation of betamethasone dipropionate 0.05% (BD spray 0.05%; Sernivo™ [betamethasone dipropionate] Spray 0.05%; Promius Pharma, LLC; Princeton, New…”
Get full text

Clinical studies evaluating abametapir lotion, 0.74%, for the treatment of head louse infestation by Bowles, Vernon M., VanLuvanee, Lisa Jenkins, Alsop, Hugh, Hazan, Lydie, Shepherd, Katie, Sidgiddi, Srinivas, Allenby, Kent, Ahveninen, Tiina, Hanegraaf, Sharon

“…Background There is a need for better control of head louse infestations. Abametapir is an inhibitor of metalloproteinases critical for louse survival and egg…”
Get full text

Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial by Tsianakas, Athanasios, Pieber, Thomas, Baldwin, Hilary, Feichtner, Franz, Alikunju, Shanavas, Gautam, Anirudh, Shenoy, Srinivas, Singh, Preeti, Sidgiddi, Srinivas

“…Minocycline efficacy for the treatment of papulopustular rosacea (PPR) has not been evaluated in clinical trials at levels demonstrated to stay below the…”
Get full text

Efficacy and Safety of Novel Formulation of Clobetasol Propionate 0.025% Cream in Indian Moderate-to-Severe Psoriasis Patients: Phase-2a, Randomized 3-Arm Study by Sidgiddi, Srinivas, Naqvi, Syed Mujtaba Hussain, Shenoy, Manjunath, Balraj, Devang Narayan, Kothari, Jayesh, Gupta, Sandesh, Haq, Rizwan, Mittal, Rajan, Mehta, Suyog, Mane, Amey

“…Introduction Clobetasol propionate (0.05% standard dose formulation), a topical corticosteroid, leads to systemic side-effects like…”
Get full text

Treatment Satisfaction, Product Perception, and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05 by Fowler, Joseph F, Del Rosso, James Q, Pakunlu, Refika I, Sidgiddi, Srinivas

“…To assess patient-reported satisfaction, efficacy, and tolerability associated with the use of betamethasone dipropionate spray 0.05% when applied twice daily…”
Get full text

Betamethasone dipropionate spray 0.05% alleviates troublesome symptoms of plaque psoriasis by Stein Gold, Linda, Bagel, Jerry, Allenby, Kent, Sidgiddi, Srinivas

“…Patients consider pruritus and scaling to be the most bothersome symptoms of psoriasis. Psoriatic plaques on the knees and elbows are widely considered…”
Get full text